PVH (PVH) is trading down at $90.14 (-4.23%) on NYSE, as of the latest quote. It is a Russell 1000 constituent in the Consumer Discretionary sector.
One firm's current price target on PVH: $91 — 1% above the current $90.1. Each is tracked to its date and scored the same way a member's call is.
1 target, newest first. Open a row for its source and scoring.
Entry price $78.2, the close nearest Oct 6, 2026, when the target was reported; the target is +16% from it.
Horizon No horizon stated, so it is tracked over the 12-month default, to Oct 2027.
Scoring Open: judged on the close on Oct 6, 2027.
Investing.com - Jefferies reiterated a Buy rating and $91.00 price target on PVH Corp (NYSE:PVH) stock.
Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. “At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.
| FY2016Jan 2017 | FY2017Feb 2018 | FY2018Feb 2019 | FY2019Feb 2020 | FY2020Jan 2021 | FY2021Jan 2022 | FY2022Jan 2023 | FY2023Feb 2024 | FY2024Feb 2025 | FY2025Feb 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $8.20B | $8.91B | $9.66B | $9.91B | $7.13B | $9.15B | $9.02B | $9.22B | $8.65B | $8.95B |
| Growth (year over year) | +2.3% | +8.7% | +8.3% | +2.6% | −28.0% | +28.4% | −1.4% | +2.1% | −6.1% | +3.4% |
| Gross profit | $4.37B | $4.89B | $5.31B | $5.39B | $3.78B | $5.32B | $5.12B | $5.36B | $5.14B | $5.15B |
| Gross margin | 53.3% | 54.9% | 55.0% | 54.4% | 53.0% | 58.2% | 56.8% | 58.2% | 59.4% | 57.5% |
| Operating income | $789.2M | $632.4M | $891.7M | $558.7M | −$1.07B | $1.08B | $470.7M | $928.8M | $772.3M | $230.6M |
| Operating margin | 9.6% | 7.1% | 9.2% | 5.6% | −15.0% | 11.8% | 5.2% | 10.1% | 8.9% | 2.6% |
| Net income | $549.0M | $537.8M | $746.4M | $417.3M | −$1.14B | $952.3M | $200.4M | $663.6M | $598.5M | $25.3M |
| Net margin | 6.7% | 6.0% | 7.7% | 4.2% | −15.9% | 10.4% | 2.2% | 7.2% | 6.9% | 0.3% |
| EPS (diluted) | $6.79 | $6.84 | $9.65 | $5.60 | −$15.96 | $13.25 | $3.03 | $10.76 | $10.56 | $0.52 |
| Balance sheet | ||||||||||
| Cash and equivalents | $730.1M | $493.9M | $452.0M | $503.4M | $1.65B | $1.24B | $550.7M | $707.6M | $748.0M | $701.5M |
| Total assets | $11.1B | $11.9B | $11.9B | $13.6B | $13.3B | $12.4B | $11.8B | $11.2B | $11.0B | $11.7B |
| Total liabilities | $6.26B | $6.35B | $6.04B | $7.82B | $8.56B | $7.11B | $6.76B | $6.05B | $5.89B | $6.89B |
| Long-term debt | $3.20B | $3.06B | $2.82B | $2.69B | $3.51B | $2.32B | $2.18B | $1.59B | $1.58B | $2.29B |
| Shareholders' equity | $4.80B | $5.54B | $5.83B | $5.81B | $4.73B | $5.29B | $5.01B | $5.12B | $5.14B | $4.79B |
| Cash flow | ||||||||||
| Operating cash flow | $902.6M | $644.2M | $852.5M | $1.02B | $697.7M | $1.07B | $39.2M | $969.4M | $740.9M | $680.4M |
| Capital expenditure | $246.6M | $358.1M | $379.5M | $345.2M | $226.6M | $267.9M | $290.1M | $244.7M | $158.7M | $142.0M |
| Free cash flow | $656.0M | $286.1M | $473.0M | $675.1M | $471.1M | $803.3M | −$250.9M | $724.7M | $582.2M | $538.4M |
| Share buybacks | $322.1M | $259.1M | $325.2M | $345.1M | $117.3M | $361.3M | $418.6M | $570.3M | $524.8M | $577.7M |
| Q3 FY24Nov 2024 | Q4 FY24†Feb 2025 | Q1 FY25May 2025 | Q2 FY25Aug 2025 | Q3 FY25Nov 2025 | Q4 FY25†Feb 2026 | Q1 FY26May 2026 | Q2 FY26Aug 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $2.26B | $2.37B | $1.98B | $2.17B | $2.29B | $2.51B | $2.03B | $2.10B |
| Growth (year over year) | −4.6% | −4.8% | +1.6% | +4.5% | +1.7% | +5.6% | +2.1% | −3.2% |
| Gross profit | $1.32B | $1.38B | $1.16B | $1.25B | $1.29B | $1.44B | $1.19B | $1.32B |
| Gross margin | 58.4% | 58.2% | 58.6% | 57.7% | 56.3% | 57.6% | 58.6% | 63.0% |
| Operating income | $183.1M | $210.2M | −$332.2M | $133.2M | $180.8M | $248.8M | $124.3M | −$190.9M |
| Operating margin | 8.1% | 8.9% | −16.7% | 6.1% | 7.9% | 9.9% | 6.1% | −9.1% |
| Net income | $131.9M | $157.2M | −$44.8M | $224.2M | $4.20M | −$158.3M | $88.0M | −$102.9M |
| Net margin | 5.8% | 6.6% | −2.3% | 10.3% | 0.2% | −6.3% | 4.3% | −4.9% |
| EPS (diluted) | $2.34 | $2.82 | −$0.88 | $4.63 | $0.09 | −$3.20 | $1.90 | −$2.23 |
| Balance sheet | ||||||||
| Cash and equivalents | $559.6M | $748.0M | $191.0M | $248.8M | $158.2M | $701.5M | $592.5M | $965.9M |
| Total assets | $11.2B | $11.0B | $10.7B | $11.6B | $11.4B | $11.7B | $11.3B | $11.4B |
| Total liabilities | $5.95B | $5.89B | $6.05B | $6.76B | $6.54B | $6.89B | $6.45B | $6.62B |
| Long-term debt | $1.65B | $1.58B | $1.72B | $2.26B | $2.25B | $2.29B | $2.27B | $2.24B |
| Shareholders' equity | $5.29B | $5.14B | $4.62B | $4.87B | $4.88B | $4.79B | $4.89B | $4.79B |
| Cash flow | ||||||||
| Operating cash flow | $28.7M | $486.5M | −$71.4M | $213.1M | −$44.5M | $583.2M | −$46.5M | $382.9M |
| Capital expenditure | $40.0M | $43.3M | $26.7M | $31.2M | $40.6M | $43.5M | $39.5M | $36.5M |
| Free cash flow | −$11.3M | $443.2M | −$98.1M | $181.9M | −$85.1M | $539.7M | −$86.0M | $346.4M |
| Share buybacks | $34.8M | $244.6M | $572.2M | $4.80M | $200.0K | $500.0K | $14.9M | $2.00M |
From PVH's 10-K and 10-Q filings with the SEC; its fiscal year ends in February. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
Read at Investing.com ↗ Link to this story
Read at Investing.com UK ↗ Link to this story
Also mentions Broadcom, Hewlett Packard Enterprise, NetApp, Netskope, Ultragenyx Pharmaceutical
PVH Corp., formerly known as the Phillips-Van Heusen Corporation, is an American clothing company which owns brands such as Tommy Hilfiger and Calvin Klein. The company also licenses brands such as Kenneth Cole New York and Michael Kors.